Log In
BCIQ
Print this Print this
 

miR-31-3p

  Manage Alerts
Collapse Summary General Information
Company IntegraGen S.A.
DescriptionBiomarker
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationColorectal cancer
Indication DetailsDetect expression of miR-31-3p in tumors of patients with colorectal cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today